Article
Integrase inhibitors to treat HIV/AIDS.
Nature reviews. Drug discovery - 1 Mar 2005
Pommier Yves, Johnson Allison A, Marchand Christophe
Abstract excerpt
HIV integrase is a rational target for treating HIV infection and preventing AIDS. It took approximately 12 years to develop clinically usable inhibitors of integrase, and Phase I clinical trials of integrase inhibitors have just begun. This review focuses on the molecular basis and rationale for developing integrase inhibitors. The main classes of lead compounds are also described, as well as the concept of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
